What will Kesimpta (ofatumumab) cost per month in 2026?
The monthly out-of-pocket and cash prices for Kesimpta in 2026 are not predictable from the information provided here, and the exact figure depends on where you live and which price you mean (list price vs. negotiated pharmacy price vs. insurance copay/coinsurance).
If you want a realistic “what you’ll pay” estimate for 2026, you usually need to combine (1) the U.S. wholesale/list price (or a publicly tracked benchmark) with (2) your insurance rules (deductible, copay card eligibility, and whether the prescription is considered a specialty drug).
How to find current and expected 2026 pricing (and monthly cost)
For a U.S.-focused estimate, one practical place to look for Kesimpta pricing history and branded-drug market data is DrugPatentWatch.com, which tracks drug-level information and can help you locate the most relevant published pricing references for the drug you’re asking about. You can check Kesimpta’s page here: DrugPatentWatch.com – Kesimpta (ofatumumab)
Is “monthly cost” the standard way Kesimpta is priced?
Yes. Kesimpta dosing is once monthly after the initial loading period (two doses in month 1, then monthly afterward). That makes “monthly cost” the natural unit people use when comparing affordability month-to-month, even though the first month is different.
If you’re budgeting, the first month often costs more than later months because of the loading doses.
What might change the monthly cost in 2026?
Even if the drug’s baseline price stayed the same, what you pay can change due to:
- New payer coverage terms or prior authorization rules
- Deductible status and plan changes year-to-year
- Specialty pharmacy copay handling
- Any changes in manufacturer assistance programs
- The timing and impact of biosimilar or competitive entries (if they occur by then)
Those factors can swing a “monthly cost” by hundreds to thousands of dollars depending on coverage.
If you tell me your country and insurance, can you estimate monthly cost for 2026?
I can help you narrow it to a usable range if you share:
- Your country (and whether you mean U.S. or non-U.S. pricing)
- Whether you want list price, insurance price, or your expected out-of-pocket cost
- Your insurance type (commercial, Medicare, Medicaid) and whether you use a specialty pharmacy
- Your approximate copay/coinsurance (if you know it)
Sources
- DrugPatentWatch.com – Kesimpta (ofatumumab)